Peter M. Clark, PhD
Dr. Peter Clark's lab focuses on the molecular imaging technology positron emission tomography (PET). The lab works on developing new PET imaging probes and assays and tries to understand the relationship between a PET image and the underlying cancer biology. The ultimate goal of the Clark lab is to develop new PET assays to better stratify patients and to predict, on an individual patient level, therapeutic responses to treatments.
Faltermeier CM, Drake JM, Clark PM, Smith BA, Zong Y, Volpe C, Mathis C, Morrissey C, Castor B, Huang J, Witte ON. Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E172-81. doi: 10.1073/pnas.1521674112. Epub 2015 Nov 30.
Yi W, Clark PM, Mason DE, Keenan MC, Hill C, Goddard WA 3rd, Peters EC, Driggers EM, Hsieh-Wilson LC. Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science. 2012 Aug 24;337(6097):975-80. doi: 10.1126/science.1222278.